STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S1703-Met Breast, STM-monitoring v Usual Care | 739 | 1 | Y | 0 Screening | 620 | 107 | 54 | 26 | 6 | 1 | 09/17/2018 | 227 | 94 |
620 | 107 | 54 | 26 | 6 | 1 | ||||||||
2 | Y | 1 Control (Usual Care) | 207 | 33 | 15 | 8 | 3 | 1 | 09/17/2018 | 227 | 94 | ||
2 Intervention (STMDDM) | 209 | 35 | 16 | 9 | 1 | 0 | 09/17/2018 | 227 | 94 | ||||
416 | 68 | 31 | 17 | 4 | 1 | ||||||||
S2417CD-Colrec Surv, Follow-up w/ CTAC site | 654 | 1 | Y | 0 | 0 | 0 | 0 | 0 | 0 | ||||
0 | 0 | 0 | 0 | 0 | 0 | ||||||||
A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | 06/04/2020 | ||||
4 | 0 | 0 | 0 | 0 | 0 | ||||||||
ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | 10/24/2018 | ||||
54 | 0 | 0 | 0 | 0 | 0 | ||||||||
ADMIN | Study |
---|---|
CCD | S2417CD-Colrec Surv, Follow-up w/ CTAC site regtype: 1 |